The Committee appreciates the government’s positive response to our 2024 White Paper recommendations, particularly the decision to lift the ban on electronic sign-up agreements in the direct selling industry.
The below suggestions aim to enhance regulatory transparency and administrative efficiency, consistent with the principles of openness and reform championed by the Lai Ching-te administration. These proposals are intended to reduce trade barriers, promote innovation, and deliver tangible benefits to both Taiwan’s consumers and retail sector.
Suggestion 1: Promote trade facilitation through clearer customs and food safety regulations.
- Enhance clarity in the application of Article 13 of the Regulations Governing the Implementation of Automated Cargo Clearance Procedures. Taiwan’s implementation of Article 13 leverages digital tools to classify imports into three categories: Channel One (C1), Channel Two (C2), and Channel Three (C3), determining whether cargo is subject to document review or physical inspection.
However, there are no consistent, publicly accessible guidelines outlining how the Customs Administration under the Ministry of Finance (MOF) determines these classifications or what importers can do to achieve fast-track clearance through C1. The absence of clear criteria hinders predictability and undermines trust in the system.
The Committee recommends that the MOF publish detailed guidance on the classification process and eligibility criteria. Doing so would enable businesses to adopt practices that support customs compliance and allow qualified importers to benefit from expedited clearance, ultimately enhancing trade efficiency and reducing supply chain delays. - Remove the requirement for overseas sales evidence or trial reports in infant and follow-on formula registrations. All ingredients used in infant and follow-on formulas (except those for special medical purposes) must meet the safety, nutrition, and compositional standards set by the Taiwan Food and Drug Administration (TFDA). Non-traditional food ingredients must be reviewed and approved by the TFDA’s Food Safety and Nutrition Advisory Committee. Prior to manufacturing, processing, preparing, repacking, importing, or exporting, products must undergo inspection, registration, and licensing by the TFDA to ensure compliance with nutrient content limits and applicable sanitation standards prescribed by the agency.
The TFDA also requires applicants to submit overseas sales evidence or trial reports for infant and follow-on formula registrations. However, this requirement does not apply to nutritionally complete and balanced foods for special medical purposes (formulas designed to be the sole source of nutrition for patients with specific medical conditions), for which the TFDA removed the sales/trial report requirement in 2019.
The Committee recommends extending this policy to infant and follow-on formulas that comply with TFDA compositional standards. As breast milk substitutes already undergo rigorous safety evaluations by the TFDA, the requirement for overseas sales or trials does not enhance consumer safety. Instead, it imposes unnecessary administrative burdens, delays market access for innovative products, restricts consumer choice, and inhibits trade. - Increase transparency in the food additive review process. This issue was raised in the 2024 White Paper and discussed during last year’s meeting with the National Development Council. The Committee reiterates its recommendation that the TFDA adopt a more transparent and participatory approach when reviewing new food additives or considering modifications to their permitted scope of use.
The Committee recommends that the TFDA engage industry experts early in the process to ensure regulatory decisions reflect operational needs and scientific evidence. Greater transparency and stakeholder involvement would enhance regulatory predictability, reduce miscommunication, and ensure technically sound, operationally feasible regulations. We look forward to supporting the TFDA in developing a structured and inclusive review framework. - Adjust avian influenza import restrictions and diversify poultry supply sources. Avian influenza outbreaks threaten poultry and poultry product supplies, often leading to shortages and price increases in Taiwan. The Committee urges the government to adopt more targeted risk management strategies to safeguard food security and consumer interests.
We recommend revising Taiwan’s blanket import restrictions by adopting a county-level ban, following practices in Canada, Hong Kong, New Zealand, and Singapore. These jurisdictions limit import bans to the affected counties rather than suspending poultry imports from an entire state, thereby minimizing disruption to trade while still protecting animal and public health.
Additionally, we suggest that the government proactively diversify poultry import sources. A more diversified sourcing policy would mitigate overreliance on a limited number of countries and enhance Taiwan’s resilience against future disease outbreaks. As part of this effort, the government should consider permitting the import of poultry and poultry products from additional qualified sources, such as Thailand, to ensure poultry availability, reduce price volatility, and support food security.
Suggestion 2: Adopt measures to improve efficiency in the food import process.
- Replace paper-based requirements with electronic procedures to advance digital governance and efficiency. The Committee again recommends eliminating paper-based requirements in the organic import permit application process. This issue was raised in the 2022, 2023, and 2024 editions of the White Paper. Despite prioritizing digital transformation and net-zero goals, the government has made little progress in this regard. Hard-copy documents and postal money orders burden importers, slow trade, and contradict policy goals. Although the Ministry of Agriculture (MOA) cites restrictions under the U.S.-Taiwan Organic Equivalence Arrangement, no provision prevents Taiwan from adopting a digital permit system.
We urge the MOA to modernize the application and review system by introducing electronic submissions and digital payment mechanisms. This step would reduce paper use, improve efficiency, and support digital government and sustainability goals. - Allow multiple packers to be listed as manufacturers of fresh produce to improve inspection efficiency and reduce redundancy. Under the TFDA’s 2024 Regulations of Inspection of Imported Foods and Related Products, importers are required to declare the “actual packer/manufacturer” for all imported food products, except for fresh produce. In the case of fresh produce, which is often sourced from multiple packers by large exporters, the exact packer may not be identifiable at the time of import. The current policy allows importers to instead declare the “foreign responsible exporter” under such circumstances. However, in practice, border inspectors have asked importers to amend this information during product inspections, resulting in the splitting of a single declaration into multiple filings. This practice has significantly increased the administrative burden on importers, led to repetitive inspections, and raised operational costs.
The Committee recommends allowing more than one packer per inspection filing when products come from the same country and meet uniform safety and quality standards. This change would streamline inspections, reduce duplication, and improve resource allocation. - Adjust tariff rates on dietary supplements to support preventive health. The Healthy Taiwan initiative, a core policy under President Lai Ching-te, emphasizes prevention and sustainable health, for which dietary supplements play a critical role.
At present, imported dietary supplements face a 30% tariff, which is notably higher than the rates imposed by key trading partners such as the United States, Japan, and South Korea, where tariffs range between 6.4% and 14.56%. In a misalignment with national health priorities, the supplement tariff is also higher than the 27% tobacco tariff.
The Committee recommends a gradual reduction of the import tariff on dietary supplements to 10%. Lowering the tariff would be aligned with Taiwan’s trade norms and improve consumer access to health products. - Refine regulatory handling of carried-over natural substances. The Committee recommends revising the checklist of common supplementary document requirements for imported food and related product inspection applications to clarify procedures when unlisted substances such as preservatives or antioxidants are detected during inspection. In such cases, literature-based background values should be recognized as the sole compliance criterion. Providing clear guidance on this point would reduce ambiguity for importers, minimize unnecessary documentation requests, and improve overall inspection efficiency. To that end, we propose the following refinements:
2.4.1 Address new raw materials and advanced processing methods. Public data may not reflect regional or proprietary ingredient variations. The TFDA should allow scientific documentation to explain differences.2.4.2 Establish standardized carryover management. The TFDA should adopt guidelines or accept raw material testing under finished products to confirm naturally occurring substances (such as salicylic acid and benzoic acid).
2.4.3 Align with international standards. We urge the TFDA to differentiate additives from flavorings (such as rosemary extract) in accordance with Codex Alimentarius standards to avoid ingredient misclassification and support global trade consistency.
- Accept electronic health certificates for imported compound food additives at Customs. The Committee notes that since 2021, the TFDA has accepted health certificates with electronic signatures for the registration of food additives. However, the port of entry still requires original hard copies for imported compound additives in accordance with Customs guidance last updated in 2017.
Electronic signatures are already accepted by the TFDA in other processes. Allowing electronic certificates at the port would enhance consistency, streamline clearance, and support digital governance and trade facilitation.
Suggestion 3: Improve regulatory transparency and efficiency in the review of food ingredients and additives.
- Enhance the transparency and timeliness of the TFDA review of non-traditional food ingredients and food additives. The TFDA’s current review process for non-traditional food ingredients and food additives lacks clearly defined timelines and offers limited visibility into review progress. As a result, the process delays market entry and discourages businesses seeking to introduce innovative products to the Taiwan market.
The Committee recommends that the TFDA establish a standard review period for applications, particularly for ingredients already approved in peer markets such as those listed under the U.S. FDA’s Generally Recognized as Safe designation or the Codex food additive list. For such cases, the total review period should not exceed one year. Additionally, applicants should be able to track the status of their submissions through a transparent and regularly updated mechanism.
Enhancing clarity and predictability in the regulatory process would support greater innovation, promote trade, and foster a more open and efficient regulatory environment. - Modernize online alcohol transaction regulations for a digitally driven and responsible marketplace. Article 30 of the Tobacco and Alcohol Administration Act (TAAA) prohibits the sale and delivery of alcohol through digital platforms. While the prohibition was originally intended to prevent underage access, this continued limitation increasingly contradicts Taiwan’s digital transformation goals and hinders retail and logistics innovation.
Taiwan’s establishment of the Ministry of Digital Affairs (MODA) reflects the government’s commitment to advancing the digital economy. However, regulatory restrictions under the TAAA have not kept pace with digital innovation. While the Committee acknowledges the MOF’s responsibility for consumer protection, its concurrent role in overseeing financial systems built on secure digital verification positions it to recognize the reliability of such tools in enabling regulated, safe transactions.
Several economies, including Australia and the United Kingdom, have adopted regulatory frameworks permitting online alcohol sales while maintaining robust safeguards against underage access. In Taiwan, digital platforms do not serve as the seller of record but function as intermediaries capable of embedding age verification technologies at multiple stages, from transaction to delivery. The challenge lies not in technological readiness but in the absence of an updated regulatory framework.
The Committee recommends that the MOF initiate structured discussions with MODA and relevant industry stakeholders to evaluate a feasible and secure model for regulated online alcohol sales. This dialogue should be anchored in three core principles:.Defining effective identity verification mechanisms suitable for online commerce.
.Requiring additional safeguards such as delivery-based age checks and digital consumption warnings.
.Enabling short-term pilot programs through a regulatory sandbox, with clear pathways to broader implementation.
Such a collaborative approach would allow Taiwan to modernize its regulatory landscape while preserving its commitment to consumer safety and public health.
Suggestion 4: Enhance regulatory clarity and international alignment for dual-use substances in food and traditional Chinese medicine.
The Committee appreciates the TFDA’s inclusion of select ingredients with dual use in food and traditional Chinese medicine (TCM) in the Food Ingredient Integration Query Platform. However, regulatory uncertainty persists during the import process, particularly regarding the final classification of products. In some cases, ingredients originally classified as food are reassessed at the point of entry by the Ministry of Health and Welfare’s Department of Chinese Medicine and Pharmacy (DCMP) and deemed to require additional fees and procedures. This lack of transparency delays customs clearance, disrupts supply chains, and exposes companies to reputational risk and unnecessary operational costs.
To address these concerns, the Committee urges the TFDA to improve regulatory transparency and harmonize standards with international practices. Taiwan can build a clearer, science-based regulatory framework that facilitates trade while maintaining public health safeguards.
- Enhance transparency of administrative procedures. We recommend that the government form a working group that brings together representatives from both the TFDA and the DCMP. This group should be tasked with clarifying regulatory principles for dual-use substances and developing guidance based on science and risk assessment.
- Align regulations with international standards. Taiwan should benchmark its regulatory practices against those of peer economies in Asia. For example, China has gradually expanded its list of dual-use ingredients to over 100 items. Japan clearly distinguishes substances that may be used for food based on their properties, while South Korea maintains a comprehensive database of permitted and restricted plant-derived ingredients. Singapore has also published a list of commonly used TCM substances that are approved for food use.
Taiwan’s current list of ingredients permitted for dual use has been reduced from 215 to just 37 items, raising concerns within the industry. Given the cultural significance and historical use of many of these substances in Chinese dietary practice, the Committee recommends expanding the list and aligning the regulatory framework with that of other advanced regulatory systems. - Strengthen government-industry collaboration. The Committee recommends that the government further strengthen collaboration with industry stakeholders to improve regulatory predictability and facilitate the lawful use of dual-use ingredients in both food and TCM applications.
First, the list of permitted dual-use ingredients should be updated on a regular basis, at least once every two years. A regular update mechanism would ensure alignment with scientific developments, international standards, and evolving market needs.
Second, the Committee suggests optimizing import-related procedures by integrating the functions of the TFDA, DCMP, and TFDA border inspection authorities into a streamlined, one-stop digital platform. Such integration reduces inconsistencies across agencies and mitigates delays at the border caused by overlapping jurisdiction or duplicative review.
Finally, public hearings and stakeholder consultations should be institutionalized as part of the Ministry of Health and Welfare’s regulatory development process. These engagements would ensure that practical industry knowledge informs policy decisions and would help support the growth of Taiwan’s TCM-related industries.
Suggestion 5: Strengthen consumer protection and trade facilitation by aligning the Tobacco and Alcohol Administration Act with international best practices.
The Committee urges the MOF to bring the TAAA and its related interpretative orders into closer alignment with international practices governing alcoholic beverages. In particular, enforcement of Article 32 of the TAAA, which requires all packaged alcoholic products sold in Taiwan to bear a manufacturing lot code, remains inconsistent. This provision is central to protecting public health, as lot codes serve as essential tools for product traceability and recall in the event of safety concerns.
Under the Consumer Protection Act, the government bears a legal obligation to enforce labeling laws that protect consumer rights. However, according to industry reports, certain local parallel importers have been removing original lot codes and replacing them with unrelated serial numbers. This practice undermines product traceability, weakens consumer protection, and violates the intent of the TAAA.
Global best practice supports maintaining manufacturer-applied lot codes. For example, U.S. regulations prohibit the alteration, removal, and/or destruction of any mark, brand, or label on alcoholic beverage containers that are sold on the market, regardless of whether that information is mandatory or voluntary. The European Union, United Kingdom, and Canada all require original lot codes to be preserved on alcoholic products. The EU Directive 2011/91/EU mandates that all packaged food and beverage products, including alcoholic beverages, display a lot code identifying the production batch. A review of OECD member states shows that 31 out of 34 countries prohibit the removal, tampering, or covering of such codes on alcoholic beverages.
The MOF has acknowledged that in 2024, approximately 0.3% of imported whisky products, representing an estimated 100,000 bottles, entered Taiwan without proper lot codes. This situation raises serious concerns about the government’s ability to effectively trace or recall affected products in the event of a food safety incident.
The Committee recommends that the MOF amend relevant laws and regulations to explicitly prohibit the removal or alteration of original manufacturer lot codes on alcoholic products. Further, we urge the authorities to strengthen enforcement through systematic inspections at the border and throughout the supply chain. This policy adjustment would not only enhance consumer protection but also improve regulatory consistency, support fair competition, and ensure Taiwan’s continued compliance with international trade norms.
本委員會感謝政府對我們2024年白皮書建議的積極回應,特別是立法通過開放直銷產業採用電子文件方式簽訂參加契約。以下建議旨在提高法規管理透明度和行政效率,符合賴清德政府倡議的開放和改革原則,同時冀望減少貿易壁壘,促進創新,並為台灣的消費者和零售業帶來實質效益。
建議一:建立更明確關務規範及食品安全法規,以促進貿易便捷化
- 提升《貨物通關自動化實施辦法》第13條適用的明確性
依據《貨物通關自動化實施辦法》第13條,海關實施電腦審核及抽驗,分別將報單核定為C1(免審免驗通關)、C2(文件審核通關)及C3(貨物查驗通關)三種通關方式,以決定貨物是否需要文件審查或實體查驗。
然而,目前沒有公開的書面條文明定財政部關務署針對上述通關方式分類的標準,或提供進口商有關符合C1快速通關之標準。缺乏明確的標準,將降低海關分類通關系統的可預測性以及大眾對該系統的信任。
委員會建議財政部關務署發布詳細的分類流程和資格標準之指南,如此將使企業能夠兼顧遵循海關規範,同時合格的進口商得以受益於快速通關,進而提高貿易效率並減少供應鏈延誤。 - 移除嬰兒及較大嬰兒配方食品查驗登記須提供國外販售證明或試用報告的要求
嬰兒及較大嬰兒配方食品(不包括特殊醫療用途嬰兒配方食品,以下簡稱「嬰兒/較大嬰兒配方食品」)所使用的所有成分必須符合衛生福利部食品藥物管理署(以下簡稱「食藥署」)訂定之安全、營養及配方成分的規定,其中新使用的非傳統性食品原料須經食藥署「食品衛生安全與營養諮議會」審查通過,產品在製造、加工、調配、改裝、輸入或輸出前,亦須經食藥署查驗登記並發給許可文件,以確保產品符合食藥署所訂之營養素限量及相關衛生標準。針對制訂有營養素限量的營養均衡完整之特定疾病配方食品(作為病人單一營養來源之配方食品),其產品查驗登記時須提供國外販售證明或試用報告的要求已於2019年刪除。針對同樣制訂有營養素限量的嬰兒/較大嬰兒配方食品,本委員會建議應比照刪除其產品查驗登記時須提供國外販售證明或試用報告的要求。
作為能滿足嬰兒與補充較大嬰兒生長發育營養需求之母乳替代用品,產品的安全性和營養充足性已可由現行食藥署的產品查驗登記審核機制達到有效的加強管理,要求另行提供國外販售證明或試用報告對於提升消費者安全無實質的助益,反而形成不必要的行政負擔,延遲創新產品進入台灣,亦限制消費者的選擇及阻礙貿易。 - 提升食品添加物審查過程的透明度
本委員會已於去(2024)年白皮書中提出此一議題,並在去年與國家發展委員會於會議中進行討論。本委員會在此重申該項建議,即食藥署在審查新的食品添加劑或研議修正其限量與使用範圍方面,能夠更透明並擴大社會參與。本委員會建議食藥署在審查或研議初期即可納入業界專家之參與,以確保監管決策能反映營運需求,並有科學證據支持。提高透明度及利害關係人的參與將提升監管的可預測性,減少溝通不良,並確保法規技術上及實際執行上均可行。本委員會支持食藥署發展具組織性及包容性的審查制度。 - 調整禽流感相關進口限制,並多元化家禽供應來源
近年禽流感已成全球重要議題與風險,禽流感爆發時將造成台灣家禽與家禽產品(如雞肉與雞蛋)嚴重短缺,食品物價高漲,爰懇請政府採取更有針對性的策略,有效預防潛在風險,以維護糧食安全及消費者利益。
目前台灣針對禽流感疫區係採全面禁止該區家禽與家禽產品進口,本委員會建議採取與加拿大、紐西蘭、新加坡和香港等地一致之管制措施做法,將對進口美國家禽與家禽產品在禽流感疫區限制區域由州改為郡,此不僅保護家禽及公眾健康外,能更精確和有效地管理,亦減少對貿易的干擾。
此外,本委員會建議政府多元化家禽進口來源,採取供應來源多元化政策將降低台灣對特定進口來源的過度依賴,並強化台灣面臨潛在禽流感疫情的韌性,對此,本委員會建議政府考慮開放自其他具合格家禽與家禽產品之國家(例如泰國)進口,以確保家禽供應無虞、減少價格波動並強化糧食安全。
建議二:採取增進食品進口流程效率的措施
- 以電子化流程取代紙本要求,以增進數位治理及效率
本委員會曾於2022年、2023年及2024年白皮書中提出,取消針對申請核發「進口有機農產品同意文件」應備紙本文件之建議,今年亦再次提出。政府雖將數位轉型及淨零排放列為優先施政目標,惟在申請核發「進口有機農產品同意文件」方面的進展甚微,該項申請要求應備紙本文件及郵政匯票不但增加進口商的負擔,亦使貿易趨緩,並與政策目標相左。儘管農業部援引台美雙邊《有機同等性協議》(the U.S.-Taiwan Organic Equivalence Arrangement)所規定之限制》,惟該協議並無任何條款阻止台灣採用數位許可證制度。本委員會敦促農業部透過引入電子文件上傳和數位支付機制來實現申請和審查系統的現代化。此舉將減少紙張使用,提高效率,並支持數位政府和永續發展目標。 - 允許將多個包裝商列為新鮮農產品的製造商,以提高檢驗效率並減少冗餘
根據食藥署2024年《食品及相關產品輸入查驗資訊欄位申報須知》規定,進口商必須申報進口食品的「實際包裝商/製造商」為製造廠,但新鮮農產品除外,因為農產大型出口商的食品來源往往有多個包裝商,進口商在進口時可能無法得知。在這種狀況下,若進口商無法得知包裝商,則可以申報「外國責任出口商」為製造廠。然而,邊境查驗人員在進行產品檢查時,因看到現貨的包裝有包裝商名稱時要求進口商進行修改,導致一份申報可能拆分成多份申報,不僅增加行政負擔及重複檢驗,亦增加營運成本。本委員會建議,當產品來自同一國家並符合一致性的安全和品質標準時,允許每個檢驗申報欄位得填列多個包裝商,這項變更將簡化查驗作業、減少重複並改善資源分配。 - 調整膳食營養補充品關稅稅率以支持預防保健
「健康台灣」是賴清德總統推動的一項核心政策,政策重點中強調預防保健和健康永續,而膳食營養補充品在其中扮演關鍵角色。
目前膳食營養補充品進口關稅高達30%,明顯高於美國、日本和韓國等臺灣主要貿易夥伴的進口關稅稅率(介於6.4%至14.56%之間),甚至膳食營養補充品的進口關稅高過菸品進口關稅稅率27%,此有悖於促進國民健康的政策。
本委員會建議逐步將膳食營養補充品的進口關稅調降至10%。調降該產品之進口關稅將符合台灣的貿易規範,並提升消費者對保健相關產品的可近性。 - 改善天然物「原料帶入」(Carry Over) 管理之規範
委員會建議修訂「輸入食品及相關產品申請查驗常見應補件態樣及補充文件種類一覽表」,以釐清當進口產品檢出未標示之物質(如防腐劑、抗氧化劑等)時的處理程序。目前僅以文獻中天然含量的背景值作為唯一合規判斷依據,針對上述檢出未標示物質之情形,政府應提供明確指導方針,以利降低進口商所面臨的不確定性,同時盡可能地減少不必要的文件要求,並改善整體查驗效率。因此,本委員會提出以下改善建議:
2.4.1 考量新型態原料與高層次加工技術:文獻數據可能無法反映所有產區或企業專有原料之差異,建議食藥署允許業者以科學文件佐證並說明此類差異。2.4.2 建立天然物原料帶入的標準化管理:食藥署可制定指引或接受原料檢測數據佐證終產品中天然存在的成分(例如水楊酸、苯甲酸等)。
2.4.3 接軌國際標準:本委員會呼籲食藥署 依循國際《食品法典》(Codex Alimentarius,以下簡稱Codex)區分添加物與香料(例如迷迭香萃取物),避免成分誤判,並支持國際貿易一致性。
- 允許輸入複方食品添加物檢附電子簽署文件辦理通關
食藥署自2021年起,已接受食品添加物查驗登記可檢附電子簽署的「產品成分報告」及「官方衛生證明」等文件。然而,在進口報關時,業者仍被要求出具正本供查驗,而該項要求係依據該署於2017年發布之「輸入複方食品添加物應檢附產品成分報告及官方衛生證明問答集」。
有鑑於電子簽署文件之有效性在其他食品查驗登記業務中已獲食藥署之認可,本委員會建請食藥署允許檢附電子文件辦理進口通關,以提升執法一致性、簡化通關流程,並支持數位治理及貿易便捷化。
建議三:提升食品原料及添加物審查之監管透明度與效率
- 提升非傳統性食品原料/食品添加物審查作業的時效及透明度
針對非傳統性食品原料和食品添加物申請案,目前食藥署未明定審查時程且審查作業流程不透明,使業界難以引入創新原料及產品至台灣市場。
本委員會建議食藥署針對非傳統性食品原料和食品添加物申請案明定審查處理期限,尤其對於已在其他國家准用的食品原料之審查及核可時程應以一年為限,例如美國食品藥物管理局(FDA)評估為「一般公認安全(Generally Recognized as Safe)」或國際上普遍准用的食品添加物(如Codex評估允用之食品添加物)。此外,建議食藥署建立透明且即時更新的審查機制,讓申請業者清楚審核狀態。提升法規流程之明確性及可預測性,將有助於支持創新、促進貿易,並營造更加開放且有效率的監管環境。 - 推動台灣酒類線上交易法規現代化,打造兼顧數位發展與責任消費的市場環境
依據《菸酒管理法》(TAAA)第三十條規定,數位平台不得販售與配送酒類,其立法原意係為防止未成年人取得酒精飲品,惟此一限制與台灣積極推動數位轉型之政策目標日益背離,亦成為零售及物流產業發展及科技創新的掣肘。
台灣近年設立數位發展部,展現政府促進數位經濟發展的決心。然而,《菸酒管理法》下法規限制未能跟上數位創新趨勢。本委員會理解,財政部作為《菸酒管理法》之主管機關一向以消費者保護為主要考量,惟財政部主管台灣財政體系,而其管理亦建立在安全數位驗證機制,因此財政部應具備充分條件認知相關科技在建立受管制且安全交易方面的可信度。
綜觀國際經驗,包括英國與澳洲在內等經濟體皆已建置完善的線上酒類銷售規範,同時透過嚴謹配套措施防止未成年人消費。而在台灣,數位平台並非直接販售酒品,而是扮演中介角色,能在購買與配送等多個消費過程環節嵌入多重年齡驗證與風險提示機制。由此可見,當前法規限制的癥結,不在技術可行性,而在於監理法規未能因應消費趨勢即時調整。
本委員會呼籲由財政部邀集數位發展部與業界建立結構性政策對話,共同研議推動合規之線上酒類交易。該對話應建立於三項原則之上:1. 建立適用於線上交易的有效身分驗證機制;
2. 導入相關配套安全措施,如配送時進行身分查驗與平台內建之消費風險警示功能等;
3. 透過監理沙盒機制進行短期試辦計畫,並於驗證可行後,據以擴大實施範圍。上述合作模式將使台灣維護消費者安全及公共健康的同時,亦推動法規的現代化。
建議四:提升法規透明度與國際接軌,促進食品與中藥材的雙重應用
本委員會感謝食藥署已將部分藥食兩用(可同時提供食品使用之中藥材)品項納入「食品原料整合查詢平台」,讓業者有所依循。然而,業者在進口通關時仍面臨不確定性,特別是在產品最終屬性的判定上。部分原獲認定為食品用途的原料,在進口通關時被要求送衛福部中醫藥司重新判定屬性,同時需額外支付費用與進行其他相關手續。缺乏透明度的情況不僅延遲通關流程、干擾供應鏈,更可能損及企業聲譽,並增加不必要的營運成本。
為解決上述問題,本委員會呼籲食藥署提升法規透明度,並與國際標準接軌。台灣可藉此建立一套更清晰、以科學為基礎的法規架構,在維護公共健康的同時,促進貿易與產業發展。
- 提升行政程序透明度
本委員會建議政府成立由食藥署與中醫藥司代表共同組成的工作小組,負責釐清藥食兩用原料的監管原則,並依據科學與風險評估制定相關指引。 - 法規與國際標準接軌
台灣可參考亞洲其他經濟體有關藥食兩用原料管理基準的法規實踐。例如,中國已逐步增加其藥食同源品項至超過100項;日本依據原料性質,明確區分可用於食品的成分;韓國則建立完整的植物性原料清單,涵蓋可用與限制使用項目;新加坡亦已公布可用於食品的常見中藥材清單。
目前台灣藥食兩用原料清單已從原本的215項縮減至僅列37項,引發產業擔憂。考量這些原料在華人飲食文化中具有重要意涵及悠久歷史,建議政府擴大食藥兩用原料適用範圍,並接軌其他先進法規體系,強化我國監管管理架構。 - 強化政府與產業的合作機制
本委員會建議政府進一步加強與產業利害關係人的協作,以提升法規的可預測性,並促進藥食兩用原料於食品與中藥應用的合法使用。
首先,藥食兩用原料清單應定期更新,至少每兩年更新一次。定期更新清單將可確保與科學進展、國際規範及市場需求保持一致。
其次,本委員會建議改善進口相關程序,可透過整合食藥署、中醫藥司與衛福部之邊境查驗單位的相關業務,打造一站式數位化平台。此整合平台將有助於消除不同機關標準不一,以及減少邊境查驗作業因職權重疊或查驗重複而延遲的情形
最後,本委員會亦建議將公聽會與產業諮詢機制納入衛福部法規制定程序。政府與產業持續對話,將有助於確保政策制定納入產業實務經驗,並進一步支持台灣中藥相關產業之發展。
建議五:《菸酒管理法》應接軌國際實踐,以強化消費者保護並促進貿易便捷化
本委員會呼籲財政部應使《菸酒管理法》及其相關解釋令更好地接軌酒精飲料行業的國際實踐。特別是《菸酒管理法》第32條與國際法規不一致,該條明文規定,凡銷售包裝酒類產品,必須標示原廠產製批號。此項規定旨在維護公共健康,因批號可作為產品有安全疑慮時據以追溯與召回產品的重要資料。
根據《消費者保護法》,政府有法律義務確保商品標示符合法令規定,以保護消費者權益。然而,根據業者調查,特定本地平行輸入廠商刪除原始製造批號並替換為無關連性之序號。這種做法破壞產品的可追溯性,削弱消費者保護,並違反 《菸酒管理法》立法宗旨。
要求酒類產品標註原始生產批號是國際慣例。例如,美國法規禁止更改、移除和/或銷毀市售酒精飲料容器上的任何標記、品牌或標示,無論該資訊具強制性或屬自願性。歐盟、英國及加拿大均要求酒類產品必須附有原廠批號,其中歐盟指令 2011/91/EU 明確要求包含酒類在內的所有食品及飲料產品均須標示原始製造商的生產批號。此外經濟合作暨發展組織(OECD)已有 31 國已禁止移除、篡改和掩蓋在酒精飲料上標示之原廠生產批號。
根據財政部2024年統計,輸入台灣的威士忌產品中,約有0.3%瓶(相當約10萬瓶威士忌)缺少適當批號標示。若發生食安事件,將引起各界高度關切政府是否能有效追溯或召回受影響之產品。
本委員會建議財政部修改相關法律及規範,明確禁止移除或篡改酒精產品之原廠產製批號標示,並透過在邊境及供應鏈上下游進行系統性查驗以強化執法。此政策調整,不僅能加強消費者保護,更能提升監管一致性,支持公平競爭,並確保台灣持續遵守國際貿易規範。
